Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory T Wolf

Showing results (151-160 of 217) with videos related to

Pageof 22
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 15, 2014
When is chemotherapy in head and neck squamous cell carcinoma not indicated?Missak Haigentz, Jan B Vermorken, Arlene A Forastiere, et al.
Head & Neck|January 17, 2012
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR statusMatthew E Spector, K Kelly Gallagher, Emily Light, et al.
Investigational New Drugs|October 11, 2015
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancerPaul L Swiecicki, Lili Zhao, Emily Belile, et al.
Oncoimmunology|December 3, 2021
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustionWang Gong, Christopher R Donnelly, Blake R Heath, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Head & Neck|February 4, 2009
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapyDouglas B Chepeha, Assuntina G Sacco, Lance E Oxford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Increased Nerve Density Adversely Affects Outcome in Oral CancerCindy Perez-Pacheco, Ligia B Schmitd, Allison Furgal, et al.
Oral Oncology|January 25, 2018
Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinomaRebecca Hoesli, Andrew C Birkeland, Andrew J Rosko, et al.
Epigenetics|June 23, 2012
Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomasJustin A Colacino, Anna E Arthur, Dana C Dolinoy, et al.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Pageof 22

Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 15, 2014
When is chemotherapy in head and neck squamous cell carcinoma not indicated?Missak Haigentz, Jan B Vermorken, Arlene A Forastiere, et al.
Head & Neck|January 17, 2012
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR statusMatthew E Spector, K Kelly Gallagher, Emily Light, et al.
Investigational New Drugs|October 11, 2015
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancerPaul L Swiecicki, Lili Zhao, Emily Belile, et al.
Oncoimmunology|December 3, 2021
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustionWang Gong, Christopher R Donnelly, Blake R Heath, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Head & Neck|February 4, 2009
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapyDouglas B Chepeha, Assuntina G Sacco, Lance E Oxford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Increased Nerve Density Adversely Affects Outcome in Oral CancerCindy Perez-Pacheco, Ligia B Schmitd, Allison Furgal, et al.
Oral Oncology|January 25, 2018
Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinomaRebecca Hoesli, Andrew C Birkeland, Andrew J Rosko, et al.
Epigenetics|June 23, 2012
Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomasJustin A Colacino, Anna E Arthur, Dana C Dolinoy, et al.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Pageof 22